跳至主導覽 跳至搜尋 跳過主要內容

Longitudinal voxel-based FDG PET assessment of chemotherapy effects on brain metabolism in lung cancer

  • Hao Wen Cheng
  • , Ing Tsung Hsiao
  • , Tsai Wang Huang
  • , Yueh Lee
  • , Qing Fang Yang
  • , I. Feng Chen
  • , Chuang Hsin Chiu
  • , Cheng Yi Cheng
  • , Li Fan Lin*
  • *此作品的通信作者
  • National Defense University Taiwan
  • Chang Gung University

研究成果: 期刊稿件 › 文章 › 同行評審

摘要

Background: Chemotherapy-induced cognitive impairment (CICI) is a frequently reported complication in lung cancer patients, yet the underlying cerebral metabolic changes remain poorly characterized. This study aimed to evaluate chemotherapy-related alterations in brain glucose metabolism in patients with non-small cell lung cancer (NSCLC) using a longitudinal, within-subject voxel-based 18F-FDG PET approach. Methods: Forty NSCLC patients who underwent both pre- and post-chemotherapy FDG PET imaging were retrospectively enrolled. Voxel-wise comparisons were performed using SPM12 to identify regional metabolic changes. Patients were stratified based on chemotherapy intensity (standard: ≥4 cycles; short-course: 1–3 cycles) and recovery interval (short: <6 months; long: ≥6 months), with subgroup and interaction analyses conducted accordingly. Results: Compared with baseline, post-treatment scans revealed regional metabolic reductions, predominantly in the right thalamus, left frontal lobe, and bilateral temporal regions. Patients receiving standard chemotherapy exhibited more extensive metabolic reductions than those receiving short-course treatment, particularly in the bilateral temporal and cingulate regions. Furthermore, patients scanned within six months post-chemotherapy showed more pronounced reductions than those with longer recovery intervals, suggesting a potential trend of metabolic recovery over time. In contrast, patients with limited initial metabolic changes (i.e., short-course group) exhibited minimal changes across intervals. Conclusion: This within-subject FDG PET study provides longitudinal evidence that chemotherapy independently contributes to brain metabolic alterations in NSCLC patients, predominantly involving the frontal, temporal, and limbic regions. These findings highlight vulnerable neural substrates and underscore the clinical value of functional neuroimaging in cancer survivorship research.

原文英語
文章編號111817
期刊Brain Research Bulletin
卷237
DOIs
出版狀態已出版 - 04 2026

文獻附註

Publisher Copyright:
© 2026 The Authors

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「Longitudinal voxel-based FDG PET assessment of chemotherapy effects on brain metabolism in lung cancer」主題。共同形成了獨特的指紋。

引用此